KIM
51
-2
PSA
53
-3
VRTX
53
-3
CAT
76
2
CL
56
-2
NWL
57
-3
IBM
67
3
HD
41
6
LB
40
-4
ALL
57
-7
UA
30
-3
FAST
48
2
DHI
41
-4
MDLZ
24
-2
VIX
40
2
KMI
63
6
A
48
-3
LH
48
-4
BAX
42
-5
NEE
57
-18
KIM
51
-2
PSA
53
-3
VRTX
53
-3
CAT
76
2
CL
56
-2
NWL
57
-3
IBM
67
3
HD
41
6
LB
40
-4
ALL
57
-7
UA
30
-3
FAST
48
2
DHI
41
-4
MDLZ
24
-2
VIX
40
2
KMI
63
6
A
48
-3
LH
48
-4
BAX
42
-5
NEE
57
-18
Financhill
Back

Oruka Therapeutics, Inc. 10K Form

Buy
56

ORKA
Oruka Therapeutics, Inc.

Last Price:
$30.89
Seasonality Move:
-4.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ORKA News And Ratings

See the #1 stock for the next 7 days that we like better than ORKA

ORKA Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-21.7M
Price / Cash Flow: 0
Annual Sales: $10.00
Price / Book: 3.09

Profitability

EPS (TTM): -2.41710
Net Income (TTM): $-101.6M
Gross Margin: $-27K
Return on Equity: -25.76%
Return on Assets: -24.74%

Oruka Therapeutics, Inc. Earnings Forecast

Key Oruka Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 27 years have been positive in 19 years.

Oruka Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ORKA
Website: orukatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 16.94
Quick Ratio: 16.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ORKA Technical Analysis vs Fundamental Analysis

Buy
56
Oruka Therapeutics, Inc. (ORKA) is a Buy

Is Oruka Therapeutics, Inc. a Buy or a Sell?